Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis. Lancet Oncol. 2019 10; 20(10):1360-1369.

View in: PubMed

subject areas

Aminopyridines
Androstadienes
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Benzimidazoles
Bevacizumab
Breast Neoplasms
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Everolimus
Female
Humans
Network Meta-Analysis
Paclitaxel
Piperazines
Postmenopause
Purines
Pyridines
Randomized Controlled Trials as Topic
Receptor, ErbB-2
Receptors, Estrogen
Receptors, Progesterone

authors with profiles

Antonio Giordano